Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies - PubMed (original) (raw)
Review
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies
Peter-Laszlo Lakatos et al. World J Gastroenterol. 2008.
Abstract
The risk of colorectal cancer for any patient with ulcerative colitis is known to be elevated, and is estimated to be 2% after 10 years, 8% after 20 years and 18% after 30 years of disease. Risk factors for cancer include extent and duration of ulcerative colitis, primary sclerosing cholangitis, a family history of sporadic colorectal cancer, severity of histologic bowel inflammation, and in some studies, young age at onset of colitis. In this review, the authors discuss recent epidemiological trends and causes for the observed changes. Population-based studies published within the past 5 years suggest that this risk has decreased over time, despite the low frequency of colectomies. The crude annual incidence rate of colorectal cancer in ulcerative colitis ranges from approximately 0.06% to 0.16% with a relative risk of 1.0-2.75. The exact mechanism for this change is unknown; it may partly be explained by the more widespread use of maintenance therapy and surveillance colonoscopy.
Figures
Figure 1
Summary of geneticalte-rations in sporadic colorectal cancer (A) and colitis-associated colorectal cancer (B). The timing of p53 and APC mutations is different; unlike in sporadic neoplasia, mutations and LOH in p53 are early events in UC-associated CRCs. The opposite was reported for APC mutations[42].
Similar articles
- Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Gurbuz AK, Giardiello FM, Bayless TM. Gurbuz AK, et al. Dis Colon Rectum. 1995 Jan;38(1):37-41. doi: 10.1007/BF02053855. Dis Colon Rectum. 1995. PMID: 7813342 - [Recent Advances in Understanding Colorectal Cancer and Dysplasia Related to Ulcerative Colitis].
Yang DH. Yang DH. Korean J Gastroenterol. 2015 Dec;66(6):312-9. doi: 10.4166/kjg.2015.66.6.312. Korean J Gastroenterol. 2015. PMID: 26691188 Review. Korean. - Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis.
Loftus EV Jr. Loftus EV Jr. Gastroenterol Clin North Am. 2006 Sep;35(3):517-31. doi: 10.1016/j.gtc.2006.07.005. Gastroenterol Clin North Am. 2006. PMID: 16952738 Review. - Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK, Rutter MD. Dyson JK, et al. World J Gastroenterol. 2012 Aug 7;18(29):3839-48. doi: 10.3748/wjg.v18.i29.3839. World J Gastroenterol. 2012. PMID: 22876036 Free PMC article. Review.
Cited by
- Is cancer a disease set up by cellular stress responses?
Aranda-Anzaldo A, Dent MAR. Aranda-Anzaldo A, et al. Cell Stress Chaperones. 2021 Jul;26(4):597-609. doi: 10.1007/s12192-021-01214-4. Epub 2021 May 24. Cell Stress Chaperones. 2021. PMID: 34031811 Free PMC article. Review. - Cell competition in primary and metastatic colorectal cancer.
van Luyk ME, Krotenberg Garcia A, Lamprou M, Suijkerbuijk SJE. van Luyk ME, et al. Oncogenesis. 2024 Jul 26;13(1):28. doi: 10.1038/s41389-024-00530-5. Oncogenesis. 2024. PMID: 39060237 Free PMC article. Review. - Inflammation and colorectal cancer: colitis-associated neoplasia.
Grivennikov SI. Grivennikov SI. Semin Immunopathol. 2013 Mar;35(2):229-44. doi: 10.1007/s00281-012-0352-6. Epub 2012 Nov 16. Semin Immunopathol. 2013. PMID: 23161445 Free PMC article. Review. - Enhancing Repair of Oxidative DNA Damage with Small-Molecule Activators of MTH1.
Lee Y, Onishi Y, McPherson L, Kietrys AM, Hebenbrock M, Jun YW, Das I, Adimoolam S, Ji D, Mohsen MG, Ford JM, Kool ET. Lee Y, et al. ACS Chem Biol. 2022 Aug 19;17(8):2074-2087. doi: 10.1021/acschembio.2c00038. Epub 2022 Jul 13. ACS Chem Biol. 2022. PMID: 35830623 Free PMC article. - The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms.
Frigerio S, Lartey DA, D'Haens GR, Grootjans J. Frigerio S, et al. Int J Mol Sci. 2021 Nov 25;22(23):12739. doi: 10.3390/ijms222312739. Int J Mol Sci. 2021. PMID: 34884543 Free PMC article. Review.
References
- Crohn B, Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis (non- specific) Am J Med Sci. 1925;170:220–228.
- Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18 Suppl 2:1–5. - PubMed
- Lakatos L, Mester G, Erdelyi Z, David G, Pandur T, Balogh M, Fischer S, Vargha P, Lakatos PL. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis. 2006;12:205–211. - PubMed
- Fuszek P, Horvath HC, Speer G, Papp J, Haller P, Fischer S, Halasz J, Jaray B, Szekely E, Schaff Z, et al. Location and age at onset of colorectal cancer in Hungarian patients between 1993 and 2004. The high number of advanced cases supports the need for a colorectal cancer screening program in Hungary. Anticancer Res. 2006;26:527–531. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous